Literature DB >> 33868653

Abbreviated Magnetic Resonance Imaging for HCC Surveillance.

Naik Vietti Violi1, Kathryn J Fowler2, Claude B Sirlin2, Bachir Taouli3.   

Abstract

Year:  2021        PMID： 33868653      PMCID： PMC8043710          DOI： 10.1002/cld.1016

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  24 in total

1.  Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas.

Authors:  Sunyoung Whang; Moon Hyung Choi; Joon-Il Choi; Seo Yeon Youn; Dong Hwan Kim; Sung Eun Rha
Journal:  Eur Radiol       Date:  2020-03-12       Impact factor: 5.315

2.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

3.  Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  Amit G Singal; Hari S Conjeevaram; Michael L Volk; Sherry Fu; Robert J Fontana; Fred Askari; Grace L Su; Anna S Lok; Jorge A Marrero
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-28       Impact factor: 4.254

4.  Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018.

Authors:  Gaurav Khatri; Ivan Pedrosa; Lakshmi Ananthakrishnan; Alberto Diaz de Leon; David T Fetzer; John Leyendecker; Amit G Singal; Yin Xi; Adam Yopp; Takeshi Yokoo
Journal:  J Magn Reson Imaging       Date:  2019-06-18       Impact factor: 4.813

5.  Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Rui-Hua Xu; Wei Wei; Michal Krawczyk; Wenqiu Wang; Huiyan Luo; Ken Flagg; Shaohua Yi; William Shi; Qingli Quan; Kang Li; Lianghong Zheng; Heng Zhang; Bennett A Caughey; Qi Zhao; Jiayi Hou; Runze Zhang; Yanxin Xu; Huimin Cai; Gen Li; Rui Hou; Zheng Zhong; Danni Lin; Xin Fu; Jie Zhu; Yaou Duan; Meixing Yu; Binwu Ying; Wengeng Zhang; Juan Wang; Edward Zhang; Charlotte Zhang; Oulan Li; Rongping Guo; Hannah Carter; Jian-Kang Zhu; Xiaoke Hao; Kang Zhang
Journal:  Nat Mater       Date:  2017-10-09       Impact factor: 43.841

6.  Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.

Authors:  O Simmons; D T Fetzer; T Yokoo; J A Marrero; A Yopp; Y Kono; N D Parikh; T Browning; A G Singal
Journal:  Aliment Pharmacol Ther       Date:  2016-11-08       Impact factor: 8.171

7.  Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience.

Authors:  Ryan L Brunsing; Dennis H Chen; Alexandra Schlein; Tanya Wolfson; Anthony Gamst; Adrija Mamidipalli; Naik Vietti Violi; Robert M Marks; Bachir Taouli; Rohit Loomba; Yuko Kono; Claude B Sirlin
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

8.  Cost-Utility Analysis of Imaging for Surveillance and Diagnosis of Hepatocellular Carcinoma.

Authors:  Paulo Henrique Lima; Boyan Fan; Joshua Bérubé; Milena Cerny; Damien Olivié; Jeanne-Marie Giard; Catherine Beauchemin; An Tang
Journal:  AJR Am J Roentgenol       Date:  2019-04-17       Impact factor: 3.959

9.  GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Authors:  Ju Dong Yang; Benyam D Addissie; Kristin C Mara; William S Harmsen; Jianliang Dai; Ning Zhang; Nicha Wongjarupong; Hawa M Ali; Hamdi A Ali; Fatima A Hassan; Sravanthi Lavu; Jessica L Cvinar; Nasra H Giama; Catherine D Moser; Katsuyuki Miyabe; Loretta K Allotey; Alicia Algeciras-Schimnich; J Paul Theobald; Melissa M Ward; Mindie H Nguyen; Alex S Befeler; K Rajender Reddy; Myron Schwartz; Denise M Harnois; Hiroyuki Yamada; Sudhir Srivastava; Jo Ann Rinaudo; Gregory J Gores; Ziding Feng; Jorge A Marrero; Lewis R Roberts
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-21       Impact factor: 4.090

10.  Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.

Authors:  Hyun A Kim; Kyung Ah Kim; Joon-Il Choi; Jeong Min Lee; Chang Hee Lee; Tae Wook Kang; Young-Mi Ku; Su Lim Lee; Yang Shin Park; Jeong Hee Yoon; Seong Hyun Kim; Moon Hyung Choi
Journal:  BMC Cancer       Date:  2017-12-21       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.